Intestinal epithelial tight junction (TJ) regulatory pathway (TJ pathway)

Intestinal epithelial tight junction (TJ) regulatory pathways represent the complex network of proteins and signaling molecules that maintain the integrity of the intestinal mucosal barrier. These pathways involve transmembrane proteins such as claudins, occludin, and junctional adhesion molecules (JAMs), which interact with intracellular scaffold proteins like zonula occludens (ZO-1, ZO-2, ZO-3) to link the junctional complex to the actin cytoskeleton (PMID: 27424725). The regulation of these junctions is dynamic and influenced by various stimuli including cytokines, pathogens, and dietary factors. These stimuli often trigger signaling cascades such as the myosin light chain kinase (MLCK) pathway, which leads to the contraction of the perijunctional actomyosin ring and subsequent opening of the tight junctions (PMID: 19383822). Dysfunction in tight junction regulation leads to increased paracellular permeability, often termed "leaky gut," which is a hallmark of inflammatory bowel disease (IBD), celiac disease, and irritable bowel syndrome (IBS) (PMID: 23426535). Increased permeability allows the translocation of luminal antigens into the lamina propria, driving chronic immune activation and inflammation. Therapeutic interventions, such as the zonulin antagonist larazotide acetate, target these pathways to restore barrier function by preventing tight junction disassembly (PMID: 22731724). Other approaches include the use of probiotics or specific nutrients like glutamine that promote the expression of pore-sealing claudins and stabilize the junctional complex. Understanding these regulatory pathways is crucial for developing targeted therapies that can mitigate the systemic consequences of intestinal barrier dysfunction.

Other names

Intestinal mucosal barrierParacellular transport systemTight junctional complexZonula occludensIntestinal permeability pathway

Modulation of zonulin signaling to prevent tight junction opening; inhibition of myosin light chain kinase (MLCK) to stabilize the perijunctional actomyosin ring; induction of pore-sealing claudin expression.